01 5Polivy
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 188
2019 Revenue in Millions : 57
Growth (%) : 231
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 266
2020 Revenue in Millions : 179
Growth (%) : 46
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 478
2021 Revenue in Millions : 266
Growth (%) : 80
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 971
2022 Revenue in Millions : 478
Growth (%) : 92
Main Therapeutic Indication : Hematology
Currency : USD
2024 Revenue in Millions : 1,235
2023 Revenue in Millions : 971
Growth (%) : 27
